Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Francisella tularensis subsp. tularensis SCHU S4, SCHU S4

>FTT0017 conserved hypothetical membrane protein
MLYRQIKTVLKIPKHTVYSLVIYSILLGFLSLTVPVSVQTLVNLVGVSLS
IRPVISLITILFIFLTAAFFVRIFQLKLVEDIQRKVFVETVLRIISAIYK
VDFNDLIRVNVREKINRAFELKFLQKSVSVIFIILLDIFLQTLFCVIILA
FYHPMFLVFDILLITCIVLVIFVPMRAGYEAGLKESTNIYDIVYWFEEKT
AEFLSFRQRPEESSVKKVDAKLCNYLDARANFFSVVLRQHVYIGLTYIFI
NILLLGIGSYLIINGQLSIGQLIAAEILVNIVLLGLLKFSQYLYDCYGFM
VAVRKILDLLEISKKDSPTSEHKNAKLETEVTSLEIALPDYQKARFDYTQ
NHFNNLCLTRQQAQKLLNAFFDDNSEEIIKINNVCLSNYSKEEICNKIHI
ASGIEVVAGTVLDNLCENDFSQEKLKYLSELLDAFGVSFLEKYFEKKIDS
QTIKYNLEFDTMVVLKMNLIRAILKHPKLLILIDSYGLTNRSNMTITQIL
QKLAVPTLIISIQ
>FTT0105c Transporter AcrB/AcrD/AcrF family
MRLIDLFIRRPVLSLSISFMIIVVGVGSFFKLQVRQYPYIDSATITVTTS
YPGANPATIQAFVTRPLEAAVGSSKGIDYMTSESALGTSTITVYVKLGYN
TNDVLSEVVQNVNSILNQLPQDAYSPAIKLNPADNFPSLILAFTSKTMNT
SEISAYINSELTPKLLAEGGLSEINVWGNMPYAMRIYPNKTRMAEYGITP
TELATAIGSNSLVSAGGQIQGPYLNYTLNPETSMSTAQEYRNLIIKKSDN
QIVRLSDVARVELGAQNYNSSVYFDGKNAVLAGAVVSPEENPLDVVNRLV
KQLPNIKASLPNGLNVDVAYNSTLYIESSIDEVLHTLLEAVIIVSIVMFL
FLGSLRAIIVPIIAIPLSIIGSFFLMSIMGFSINLLTLLAMILAIGLVVD
DAIVVLENIYRHIEEGMEPFAAAIKGAREIANPVILMTLTLIVVYAPIGM
MGGFTGQLFTEFAYSLAGAVLISGIVAYTLSPMMCSKVLNREMMSSKLVK
FIDNVFSKLAAKYKALLMFVLDIKPAIAIVGIIVLASCFIMGKGIKSELA
PNEDMGFLGVMGQAPSSANINYLETFGKKLANTLDEIPGKQNVFILNGIM
SSNVIFGGFIMQPWDERKISQQQAANIAQAKVTELPGVQTYTYQTPALPG
IPRGAPLSLVIQSVNDYEAIDEITNKIIAKMMSNGLFVFAQSDLKFDNPI
VDINIDRDKAGILGITMSDIAKTLGYSYAGGYINYFFLKGYSFQVIPQLA
RNEMLTQEQLGNIYIRSDEMNKLFDSEVPLSALVTFKTEGQPLTLNTFQQ
LNASTISAVMAPGITQGQAIEYVQSVVKSMLPEGFSYNFSGSARQYIENG
NTMMVAFAFAIVLIFLALSAQFESFRDSLVILVTIPMAISGALIPLYVGQ
YLGASWASLNIYTQLGLVTLIGLISKQGIMVVEFANHLQKHNGMNKYDAI
VTSSSQRLRPILMTVSAMVVGVIPLVTSSGAGAISRNCIGVVISSGLVIG
AIFSLFVLPVVYMYIASDKSKLVKTDAEQQQIIDQIK
>FTT0523 conserved hypothetical protein
MVELNNFLSKANIEWVKIQDKESYPILGVRGQGQGVYINRIANGKELTMK
KYQKSEPYHLFFCKVRTVKGQWGVVYPEYANSYASSNMQYLKIDLDKILP
EYLEMLLKLKKITDIWDKNAIGADGRHFPLKILLTLQIPLPPIEIQKQIV
QAYEDKINLANQLEQRAEKLEAKIEKYLYAKLGIEQAQEQKQDKKGLLKF
VRFEQLQRWDTDFFKQKEGYSSKYETVSYEDLFVSLNNGIAARNYASDGI
RYLKVSDIKDNYINNDKPFYVNKYKESDLIEKGTLLITRKGTVGNSYYLD
KDGSFVASSEIFIIKLNDKVNGNYLSEINLSSFVKKQYREKSTGTIMPSL
SQPKLKSILIPLPPLKIQNHIAVRIQKLKDYIKALEQQAEQNRENALRNF
EVEIFSKE
>FTT0611c beta-lactamase
MRLLVTTLSLIPSIILAAPQLDDSFKNLENKYDGKIGIYTLNTDDKTNIK
YNESYHFPICSVFKFLLVGAILDYDMHNQGFLDKKIPINQDDIGKLGYAP
ITAKNVGKTLTISQLNYAAILSDSPASNILVRELGGLQNLNKFIKKLGDN
DTIITADEPEINYTQPHSNINKTTPKAITKDIYKLAFGNILDKKHKDIFI
KYLQDNNTGANRIAFSMPKDWIIGDKTGTCGQYAATNDVAIIWPKNQQPI
ALGILYTNPNDKNAPSNEEIIQQAAKLIANDLTNTYK
>FTT0090c conserved hypothetical membrane protein
MKNQKSIDVYLAYSGLIPFLFFTICLLFNYKHTLIFGNTIQALSIYGLII
ASFLAGTHWGRQINIESPIVKLLLQISSNINVITIWFAYLNLNSKYFILL
LIIEFLVLLKIDYYIYKLKITSSRYFLYIRLPITIAVVILLAISWSLI
>FTT0747c conserved hypothetical protein
MGINMSNKNTKSIISIIIILFALFSLYAMWQYYLYSPWTRDGRIRAKIIT
IAPDVSNMYVSDNQKVKKGQLIFTIDDQRYAATLEGKEAELKHAMIEWQL
AEKQYLRRIRLGRDDSISREELDDYAMQEKLRKADLEKAKAEAELAKINL
DRTKIYAPADGTINNIDLRQGNYVVSSKPVMSLVKAGSFYVTGYFEETKL
PHIKIGDKAKIILMSGGEPLYGHVISIGKAVTDNNTDVNNQLLPKVQETY
DWVRLSKRIDR
>FTT1579c Type III restriction enzyme
MLFEKQQYQEDCVNNIVNILDECDVFNNDYSNLKNIIKEHYKTQRYSQFE
TSSKKQIDVLMETGTGKTFTYIKTIFEINKQFGKTKFIIVLPRTAIKQGV
IQNIKLTDEYFYNEYGKHLKFIDYTGKDSLSAVQQSFIRNESDLTVLVST
NSAFNKDANTINQAKEDLVEHSSVWEAIADKKPIVFIDEPHLLKGGATVE
ALEKLDSLFIRFGATYPTEEEHKLVNVAYALDSINSFENYLVKRIAVKNI
LTGAEESDIKITKINAKGKQSDKSVTFSYSKNQQIYSTTIKIGDDVGSKT
GLDIYHGVTLTKINAKEIFFSNGDTKKVSESYELNDDEIEQMLRVTVSNH
FEKEERLFNQGIKELSLFFIPSIADFRGDNPRVRKFFEKIYREIRDEYYH
NTTNQEYKKYLDKDFKDGKLQVLEGYFSGDKGDNAKDDDLKKAVDIILNK
KEQLLSLDEPLRFVFSVWALQEGWDNPNIFNICKLATTDKETSRRQQVGR
GLRLAVNQAGKRQSFKTLAENENAFYDINTLDVVVSGYEKDFIEGIQSEI
QKASFGIVGDFLENSLLEANGLNLREISKLINTLEDNQIIEFDESIEKYK
IISSIYDFIENNADKLSFLSNDRLQEIKQLFKSRKSLIEDKNKTIEKLKI
RQEQAKKFKELWETINRKAEIVYKDINELDIINKIADAFDTENFSQIDTK
IITKVYDPIKDKVVTKEEQSLGKIDFFAKNKLSEFVFEFSKKEKLPLGFV
TKLFSKLDLQKIKNNPSKAINFIKTQIKESIHTSILQCVDYDFSQTNIFS
KNILQNDDGSFIKEIEYTKLGRNIGDEASDEFLFDRVVYDSDIEKQAILN
DPTSIDGQQITVFAKLPSISIPTPYKAYNPDFAYFIDRGENQKQLFLVVE
TKGYKNNSDILQAEKTKIDYAKKFFEGLQKQLPDVEIRFKTRVNKQELSN
ILQEYQK
>FTT1066c hypothetical protein
MYVNKHFMRNNMKNIPISYLTLLSRQINSAISDGYIESYSFEDIYNAIDN
KNLEKIVTNEVADFGILSTIQKDELEWLYQQLAYEAKKFSDAGNERAKLD
LDNKKHGLSLLLGMILEIIQSHYN
>FTT0793 ABC transporter, ATP-binding and membrane protein
MKQFFKYFIGILDTTQKKRFFLYLVLLFLGSTSSMLGVGAVIPFVNALIN
PKYFDNIVILRSFSNFQIILISIVLLILAFWIKNIIGVILFWFQTKFLNS
IVLDIQKKLFRLYILMDYESHLTRSTPTLIRNINSETNQLSSGIINPLGI
LMTDLFSCVFIVALLLYINFLFSFFTLLILGVSLFIFMLKIKGILDKYGK
QRAEAWKSMTQTTMNGLSGIKEIKLYNKEKVFMSEFDEKAAMLNRSMQFN
QIFQILPRFFIEAIAITFVLVTLLVLIVFSESINSIFILLSVFGVAATQL
LPALNRIMQAITNIKYSIPALKVIYEELSKYQNYSDSIENSHQLDISFEK
NIRLENISYSYPDGTQALKNISLTIEKGKKTAFIGPSGSGKSTLVDLLMG
FYTAQSGSIYIDDKQINNTWIVQRLFAYIPQQIILYDTSIKQNIAFGEPK
TLIDEAKVWKCLKMAQLDDFVSKLNKGLDTFVGENGVRLSGGQRQRLGIA
RALYQNPQILVMDEATSALDNEIEKEVTNVIKELKDITIITIAHRLSTIE
GYDMVYSLNN
>FTT1798c hypothetical protein
MSKRFTEDHYQKICTDLEYREKLIKNPKLTLNEEYGTTINDEVNVEVIEQ
SDDAITIILPAKPDNQDDIESELETVTEQVVDLLFTHDGMGGFLIPDDNL
KWELRNMRKDWMKKLGLDLENS
>FTT0101 conserved membrane hypothetical protein
MLLKNNYLVSIILVVLIMIVTKSFACAATDYNKVALINVSTQYYPNDIKQ
AEKALKDTGYNTTYKYLDIYPSDFGYSNPDSIRAKILLDALLDKNIDIIW
FLKGGGGAFNLLPYLYDHINELKKAKPKILVGFSDVTAIHFFVNNVLGWK
SLHGVVAAYNKNAYSSQKIGKIRINDLERIPNITEIINNGISYDKLMPMN
KMAYNGIDGSIVGGNMTLIYSYFSTVYQQDISTKILFLEDTGISFRQLDR
SLHQLLYLPENKKPEAIIFGQFYPLDPTDDQRLIYKTVIKKFAKTFNRPV
YYFPFIGHGQYNKPLLLGVTSNIKCSKETIFCTLKQK
>FTT0522 conserved hypothetical protein
MARVSKMNMIMHGDGHNGIHHNDGLLNVNGIFRNRFDVILTNPPFGTNLG
KDNSKVSEEDKYTDEKMITHYKKIYGDVYEEELKQVTDNFGKPIRSLYKT
GEISVATEVLFVERCLDLLKAGGRMGIVLPEGVLNSSNLQKAREYFESRA
KILLIVSLPQDLFVSSGATVKTSLVFLKKFTVEEQEQYETVKTQAEKEAE
QKYQPQLLEIQQKIDFEKSIKQHITKLRKALKTKTAKNKENLQLTLDETI
VEHTEYKKKVKQYKAQLKELEAKQQEEAKQLIKQKFDYEIPIAEIEKAGV
STIGAEIDNQLPELLKEFKEYYKRK
>FTT0162 ampD, N-acetylmuramoyl-L-alanine amidase
MFNQGWYKKAKCIKSPNFNQRADKNDINLVVIHCISLPEGGYANCNVEKF
FTNQLDCSLHPSFASLKGVEVSAHFYIKRDGEIVQFVSVDDRAWHAGVSE
FQGRQGCNDFSVGIELQGTDKTAYTEQQYLSLNSLLKDLRKAYPTLLNIT
GHEDIAPQRKTDPGKCFEWNKVIW
>FTT0681c blaA, Beta-lactamase class A
MKKIITLIIGIIFITFSFATTKIDTQVTNDIQNIEKKHGGKIGVYTINRN
DWSNFAVNASFYFPICSTYKFLVVGAILKQSMTDNKLLNQKIKISKNQIV
EYSPITRRHINQIMTVKQLCQASMQGDNTATNILIEKLGGLKNLNKFILS
LADHATKVANLEPKVNHVSLTTNENKTTPKIMARDINKLAFSDDILDKKH
RLMFKQWLIASNTSNNRIAAEVPDEWEVGDKTGTCQYGTTNDVAIIWPDD
NRAVIMAIFYTQSQKNAKPNSKIVREVTKILLNRLQLNNTTKNA
>FTT1257 emrA1, HlyD family secretion protein
MSEEKLQQSTITRNKKSSRFSPKKIIIGSSIITITALGIYGYYKYNKIFP
STDNAYVNADIISISPKVGGYIEKVYIHNNQFVHKDDKLVQIDPKDYQLK
VAQANSKIIQTKGQLAIAQEQVNVAKSNLTKAQSSLDTATSMADRYIKLY
KDDAGSLQDAQKYINQKIQAQKAKDEAYSSLKQALLQVEIAKAQIGAAKL
SYDNANLNLGYTTLIAPDDGYVSNLKLYKGQLVSPEQALFGFIDNKKWWI
DANFKETDLDRIKPGQKVEIELDMYSHSYAGKVDSISYATGSVFSLLPPE
NATGNWVKVTQRFPVKIILKNDPKYPLRVGASATVKVDTL
>FTT1654 emrA2, HlyD family secretion protein
MKISKLMATVIILFIIIFLICVFLFFDASFERDAYLYADFTRVNSVENGQ
VEKIYIKKGSYVKKGDTLFVLDCRYITKELNILKSQEKKIALELKDIVIK
IKLAEKQRDLTKDSLIVEKRNFERYRILIKEGAVSAQQKDLAEKSLISSE
SQFVRACQNVDNLKIRQNDLLSDQKITQSKIDQKQYSLSRCSVKATTNGY
ISNFILEEGDFIKKGQELFSIVDTDKWYVVANVKESNIKYLSVGQIVTMT
TSLTGIKKYKGKIVDIEKGITRPEYNNFSALYNIERNIDWVRLDYRFPVL
IEVLSKDTKEFRLGGDVHVWF
>FTT1171c hsdM, DNA-methyltransferase, type I restriction-modification enzyme subunit M
MVENRSMQSKINRITDILRRDDGISGAMHYTEQVSWILFLKFLNDYENEK
SLEAELIGEDYIFVLDEKYRWNIWAAPKGADGKLDVINADTGDDLLEIVN
KELFPYLKSFKSIDEDVKSLKYKIGAIFEFLDNRIASGHTLRDVINEIDE
LNFNKKEDLYQLSQIYENLLKEMGSDGGNSGEFYTPRPLVKAIVDVVNPQ
AGQTVYDPAAGTCGFLIDAYEHMYSKELSTTQLKFLNEETFFGKEKTPLS
YVMGVMNMILHGITSPNINKANTLVKDIRSLEEKDRYDIILANPPFGGKE
KATIQTNFPIKSNATELLFLQHIYKSLKLGGRCGVVVPEGVLFQTNNAFK
NVKKELLENYNVHTIVSLPAGVFLPYSGVKTNVIFFDREGSTTDIFYYEV
NPPYKLTKNKPIQFEHFAEFLEIWQSRKLTYNSWIVNVTDIKDYDISAKN
PNKVETIEHKSPTQLVNEIKQNTAEINKLMSEIESIIQ
>FTT0405 lolD, lipoprotein releasing system, subunit D, ABC transporter, ATP-binding protein
MNDVVLSCKNVSKKYTEFKTDIAILKDVNLEIKKGEKVAILGLSGSGKTT
LLNVLGGLDKCSAGEVYLMGERFDNQSVNKRAKMRNKHLGFIYQLHHLLP
EFTAIENVMIPLAITKKYTKKESIKLANEILKKVGLDHRADHKPAELSGG
ERQRVAIARALVTNPNCILADEPTGNLDSQRSESIFALMQQLSDDFGTSF
VIVTHDEKLASRMNKIYRLVDGELELVINSN
>FTT0109 valA, Lipid A transport protein, ABC transporter,ATP-binding and membrane protein
MANMIDKIDLKSQGSSNLSGEMTNHQKVGTLYKRLLLQVKHLWHFLLLAA
IGSIFFSAADASMIYLINPILNYGFGPGGGITKQSATILMLMGVGMVGLL
ALRSVGSFVSQYFIGSLGQKVVYKFRKDIYKRLMDLPASFFDKHSTGQII
SRLLYNVDQVIEATSTAIITVVQDGTFVIGLIVVMFVSSWQLSLFLIVVG
PFLGLFISIINKKFRNLSRNTQSSMGNVTHTAEETIRNYKEIRIFGAQQK
QQNKFFKNLDYTYSQQIRTIALDALTSPVIQIIASLVLAFSLFTIAIFGT
NEGDGSSWLTAGSFASFFAAAAAILKPIKNLTKVNVVIQKAVAATEDIFY
ILDYPAEKETGSKELAKVDGNVTIKDLSFAFGEHKVLSGVSVDIKAGQTV
AFVGKSGSGKTTLTSIISRFYTQHEGEILLDGVDTRELTLENLRSHLSIV
SQNVHLFDDTVYNNIAFGLSREVSEEEVIDALKRANAYEFVQELSDGINT
NIGNNGSKLSGGQRQRISIARALLKNAPVLIFDEATSALDNESERVVQQA
LESLTKSCTTIVIAHRLSTVENADKIVVMDGGRVVESGKHQELLEQGGLY
TRLYQSGLQ
>FTT1434c yadH, ABC transporter, membrane protein
MNLRDYWITYVTIFNRECKRVFRIWPQTLLPSVITIVLYFLIFGKVVGSR
IGSMGDGVTYMQYITPGLIIMAVIQNSYGNVVSSFFGIRFSKAIEELLVS
PVSNHLIVLGYISGGIFRGFIVGMFVSVAAFLLGGFATIHNVPLVLAGFI
FCGALFSLGGLINAIFSQKFDDTTIFPTFILTPLIYLGGVFYNINNLTGF
WHFISSCNPLFYIVDFVRYGFIGVSTVNPYFAFAAIVIFTFVLYYLCWYL
LEKGIRLKA
>FTT1435c yagD, ABC transporter, ATP-binding protein
MDNQKALEIKNLTKVYKGGLKAVDDISFEVKKGDFFALLGPNGAGKSTTL
GMISSLVNKTSGQIKIFGHDIDTDYIQARKHLGVMTQEINLNIFEKPIDI
LITQAGFFGISKKDAIPYAEELLKKVDLYEKRNTQVRFLSGGMKRRLMVV
RALIHKPKLLILDEPTAGVDVELRNSLWEMISEFHREGLTIILTTHYLEE
AESMCKHIALINKGKLSVNTDMKTFLKSADKHTYIFDLKDKCQQEIKLDL
GEVKRVDDYTIEVEVSKGVVLNQIFAELSSKYDLDVLDVRSKAAKLEKLF
IEVARNK
>FTT0728 ybhF, ABC transporter, ATP-binding protein
MISDKDDQLIIDVKNLTKVYGDKNVVDNISMQVKQGDIYGFLGPNGSGKT
TSIRMVCGLLPITKGEGTCLGYDIGTHASIIKQQVGYMTQKFTLYPDLTV
RENLKIFARLHSLKNIKEAVDKTIDNLQIGKARANQKAYELSGGWKQRLA
LGVATIHDPKLLLLDEPTAGVDSKARREFWDYISTLSSKGITTLVSTHYM
DEAERCNKLSYIAYGKLLSSGTQKDIIDSCGIKTYNISGKNVYSLVLELQ
DNTEIEHVSMFGSSVHLSVKNNVDITHIQTKYEQFEWQSIETSLEDAFIY
LMSSQKDNFA
>FTT0729 ybhR, ABC transporter, membrane protein
MKYFDINRYYAIFLKEVIHMLRDKVTIGLVIGIPLIQLILFGFAINMNPK
HLSTAIVNADKTLQTNYLIEKINNTGYFDIKYENISRDDATTLMRKGKVQ
FIIDILPNFTKQVYRGESPNILIIVDGANATSNSGALQAVDKVKEIYSQY
FSNKQIPQPQSFNFVIHNKYNPENKTQNNIVPALAGVILTMTMVMVTSLI
ITREKEYGTMESLLATPVTSLETIFGKITPYIVVGYIQLLLIIIFAKVIF
GITIVGSILLLLIVTFPFIIANLLVGITFSTIADTQLQAMQMTFFFFLPS
ILLSGFMFPFDGMPEWAQVIGNILPLTHYLNIVREILLKGGGFFDILNSI
YPLLIFMIVVSFICIKKYKNTI